Topic: Strategy
Forgoing a Tax Refund to Signal Brightening Financial Prospects
Companies that use loss carry-forwards to offset future tax liability, instead of claiming a refund, enjoy favorable lending terms
Green Initiatives — By Themselves — Won’t Boost Productivity
Environmentally conscious companies that also instill teamwork and quality enjoy higher output
Household Waste Reduction Gets a Lot of Study — But Institutional Settings Are the Bigger Opportunities
Growing tension between behavioral research focused on the individual and the study of societal systems
How Banking’s Bifurcated Deposit Approach Is Altering Lending — and Risk
Offering higher deposit rates lessens emphasis on loans of fixed rate and longer maturity
How Dollar Stores Contribute to Food Deserts
Expanding chains drive out independent grocers, reduce access to fresh produce
How Fake Customer Reviews on Amazon Distort Markets
Shoppers’ highly imperfect understanding of the problem leads to poor buying decisions
How Nonprofits Can Better Engage Volunteers
When to allow unpaid workers to call dibs on recurring tasks — and when not to
How Organizational Hierarchy Hinders a Platform Aimed at Worker Collaboration
NASA employees engaged when it was clear their bosses were on board
How Publicly Funded Research Leads to Cancer Drug Trials
Pharmaceutical companies are better able to identify promising new applications for existing drugs
How to — and How Not to — Message Older Americans
Practitioners often ignore decades of progress in understanding what works
How to Properly Incentivize Your Unicorn Finder
VCs and other investors need a contract with their seeker that blunts conflicts of interest
How to Spur Capital Spending: Plan for Failure
Companies might invest more in new ventures if they could see in advance how to redeploy the assets if things don’t pan out
How Universities Can Behave Like Entrepreneurial Organizations
Tradition bound, colleges face pressures to be nimbler, more opportunistic
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
In COVID-19, Should the Logistics Tail Have Wagged the Vaccine Dog?
Balancing vaccine efficacy against need to quickly inoculate more people